Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2525-2536
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2525
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2525
Variables | Comprehensive geriatric assessment | Fried phenotype | FRAIL scale | ||||||
Non-frail (n = 78) | Frail (n = 151) | P value | Non-frail (n = 120) | Frail (n = 109) | P value | Non-frail (n = 149) | Frail (n = 80) | P value | |
Male, n (%) | 53 (67.9) | 88 (58.3) | 0.154 | 78 (65.0) | 63 (57.8) | 0.263 | 96 (64.4) | 45 (56.3) | 0.225 |
Age, yr | 66 (57-71) | 68 (62-76) | 0.020 | 65 (57-71) | 70 (63-76) | < 0.001 | 66 (58-72) | 69 (63-76) | 0.012 |
BMI, kg/m2 | 24.45 ± 3.47 | 23.33 ± 3.39 | 0.021 | 24.35 ± 3.12 | 23.0 ± 3.68 | 0.003 | 23.95 ± 3.27 | 23.27 ± 3.75 | 0.158 |
Smoking history, n (%) | 35 (44.9) | 71 (47.0) | 0.757 | 62 (51.7) | 44 (40.4) | 0.087 | 76 (51.0) | 30 (37.5) | 0.051 |
Drinking history, n (%) | 32 (41.0) | 68 (45.0) | 0.562 | 61 (50.8) | 39 (35.8) | 0.022 | 70 (47.0) | 30 (37.5) | 0.168 |
Neoadjuvant therapy, n (%) | 2 (2.6) | 10 (6.6) | 0.321 | 4 (3.3) | 8 (7.3) | 0.174 | 5 (3.4) | 7 (8.8) | 0.151 |
CCI score, n (%) | 78 (100) | 0.001 | 0.091 | 0.003 | |||||
0-2 | 0 (0) | 133 (88.1) | 114 (95.0) | 97 (89.0) | 143 (96.0) | 68 (85.0) | |||
≥ 3 | 0 (0) | 18 (11.9) | 6 (5.0) | 12 (11.0) | 6 (4.0) | 12 (15.0) | |||
Polypharmacy, n (%) | 6 (4.0) | 0.178 | 1 (0.8) | 5 (4.6) | 0.173 | 0 (0) | 6 (7.5) | 0.003 | |
Upper arm circumference, cm | 29.5 ± 2.5 | 28.2 ± 2.9 | 0.001 | 29.3 ± 2.4 | 27.8 ± 3.1 | < 0.001 | 29.1 ± 2.6 | 27.8 ± 3.1 | 0.001 |
Waist circumference, cm | 89.8 ± 9.8 | 87.5 ± 9.7 | 0.091 | 89 ± 39.4 | 87.1 ± 10.0 | 0.099 | 88.7 ± 9.8 | 87.3 ± 9.6 | 0.303 |
Hip circumference, cm | 96.4 ± 6.3 | 93.6 ± 7.4 | 0.006 | 96.0 ± 6.0 | 92.9 ± 7.9 | 0.001 | 95.1 ± 6.7 | 93.7 ± 7.9 | 0.157 |
Calf circumference, cm | 34.8 ± 3.2 | 33.0 ± 3.4 | < 0.001 | 34.8 ± 3.0 | 32.3 ± 3.5 | < 0.001 | 34.2 ± 3.2 | 32.5 ± 3.6 | 0.001 |
HB, g/L | 130 (109-137) | 116 (97-133) | 0.003 | 130 (114-141) | 108 (92-128) | < 0.001 | 127 (111-138) | 106 (87-128) | < 0.001 |
WBC, 109/L | 5.75 (4.50-6.84) | 6.00 (4.70-7.22) | 0.184 | 5.85 (4.52-6.97) | 5.93 (4.72-6.90) | 0.598 | 5.80 (4.53-6.81) | 6.00 (4.76-7.54) | 0.186 |
Platelet, 1012/L | 209 (178-244) | 228 (186-270) | 0.171 | 212 (181-249) | 228 (186-274) | 0.255 | 219 (179-254) | 227 (190-278) | 0.265 |
Lymphocyte count, 109/L | 1.56 (1.17-1.97) | 1.39 (1.07-1.77) | 0.070 | 1.47 (1.17-1.96) | 1.40 (1.04-1.74) | 0.046 | 1.44 (1.16-1.94) | 1.40 (0.92-1.74) | 0.067 |
Lymphocyte ratio, % | 28.6 (23.0-33.0) | 23.5 (18.4-31.3) | 0.002 | 28.2 (21.8-33.3) | 23.4 (17.3-29.1) | 0.003 | 27.6 ± 9.2 | 23.5 ± 9.7 | 0.013 |
Creatinine, μmmol/L | 63.4 (53.8-71.0) | 58.2 (48.5-72.3) | 0.127 | 63.6 (54.4-73.2) | 55.3 (47.0-67.5) | 0.001 | 62.5 (52.6-72.5) | 56.7 (47.3-69.5) | 0.074 |
Haematocrit, % | 39.3 (34.1-41.9) | 35.4 (31.3-40.5) | 0.003 | 39.3 (34.9-42.8) | 33.5 (29.4-39.0) | < 0.001 | 38.8 (34.1-41.5) | 32.7 (28.0-39.1) | < 0.001 |
Albumin, g/L | 38. ± 13.7 | 36.4 ± 4.0 | 0.002 | 38.4 ± 3.5 | 35.4 ± 3.9 | < 0.001 | 37.8 ± 3.7 | 35.4 ± 4.0 | < 0.001 |
Total protein, g/L | 62.7 ± 5.8 | 61.2 ± 5.9 | 0.059 | 62.8 ± 5.6 | 60.5 ± 6.0 | 0.003 | 62.4 ± 5.4 | 60.4 ± 6.6 | 0.011 |
ASA classification, n (%) | 0.036 | 0.009 | 0.011 | ||||||
I-II | 55 (70.5) | 85 (56.3) | 83 (69.2) | 57 (52.3) | 100 (67.1) | 40 (50.0) | |||
III-IV | 23 (29.5) | 66 (43.7) | 37 (30.8) | 52 (47.7) | 49 (32.9) | 40 (50.0) | |||
KPS score, n (%) | < 0.001 | < 0.001 | < 0.001 | ||||||
≥ 70 | 76 (97.4) | 118 (78.1) | 119 (99.2) | 75 (68.8) | 144 (96.6) | 50 (62.5) | |||
< 70 | 2 (2.6) | 33 (21.9) | 1 (0.8) | 34 (31.2) | 5 (3.4) | 30 (37.5) | |||
Cancer type, n (%) | 0.011 | 0.216 | 0.104 | ||||||
Stomach | 18 (23.1) | 65 (43.0) | 40 (33.3) | 43 (39.4) | 49 (32.9) | 34 (42.5) | |||
Colon | 32 (41.0) | 49 (32.5) | 40 (33.3) | 41 (37.6) | 51 (34.2) | 30 (37.5) | |||
Rectum | 28 (35.9) | 37 (24.5) | 40 (33.3) | 25 (22.9) | 49 (32.9) | 16 (20.0) | |||
Operative method, n (%) | 0.005 | 0.008 | 0.187 | ||||||
Open surgery | 13 (16.7) | 52 (34.4) | 25 (20.8) | 40 (36.7) | 38 (25.5) | 27 (33.8) | |||
Laparoscopic surgery | 65 (83.3) | 99 (65.6) | 95 (79.2) | 69 (63.3) | 111 (74.5) | 53 (66.3) | |||
Operative time, min | 156 (123-202) | 169 (120-210) | 0.578 | 165 (120-217) | 163 (121-195) | 0.486 | 165 (125-210) | 160 (119-200) | 0.412 |
TNM stage, n (%) | 0.057 | 0.328 | 0.911 | ||||||
I-II | 55 (70.5) | 87 (57.6) | 78 (65.0) | 64 (58.7) | 92 (61.7) | 50 (62.5) | |||
III | 23 (29.5) | 64 (42.4) | 42 (35.0) | 45 (41.3) | 57 (38.3) | 30 (37.5) | |||
Histological grade, n (%) | 0.012 | 0.545 | 0.374 | ||||||
Poorly differentiated | 28 (35.9) | 78 (51.7) | 55 (45.8) | 51 (46.8) | 67 (45.0) | 39 (48.8) | |||
Moderately differentiated | 33 (42.3) | 55 (36.4) | 43 (35.8) | 45 (41.3) | 56 (37.6) | 32 (40.0) | |||
Highly differentiated | 17 (21.8) | 18 (11.9) | 22 (18.3) | 13 (11.9) | 26 (17.4) | 9 (11.3) | |||
Postoperative length of stay, d | 14 (12, 16) | 14 (12, 19) | 0.184 | 14 (12, 18) | 15 (13, 18) | 0.162 | 14 (12, 17) | 15 (13, 19) | 0.029 |
Hospital costs, RMB | 62341 (58067, 71180) | 67697 (59097, 81720) | 0.006 | 63148 (57893, 74841) | 67764 (59156, 82804) | 0.047 | 63477 (57719, 76170) | 69031 (59596, 82043) | 0.023 |
Severe complications, n (%) | 6 (7.7) | 23 (15.2) | 0.104 | 13 (10.8) | 16 (14.7) | 0.382 | 16 (10.7) | 13 (16.3) | 0.232 |
- Citation: Zhang HP, Zhang HL, Zhou XM, Chen GJ, Zhou QF, Tang J, Zhu ZY, Wang W. Predictive value of frailty assessment tools in patients undergoing surgery for gastrointestinal cancer: An observational cohort study. World J Gastrointest Surg 2023; 15(11): 2525-2536
- URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2525.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2525